Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider
View original at globenewswire.comHuman Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider Austin, United States, Feb…
O que extraímos desta fonte
The claims Via News extracted from this document. We point to the source; we don't replace it.
The U.S. Human Vaccines Market is expected to grow from USD 11.72 billion in 2025 to USD 15.17 billion by 2033, registering a CAGR of 3.30% during the forecast period
80% confidenceThe Human Vaccines Market is driven by the rising awareness of preventive healthcare, expansion of national immunization programs, and rising cases of infectious and chronic diseases
80% confidenceThe Asia Pacific Human Vaccines Market is the fastest-growing globally, projected to register a CAGR of 5.89% during 2026–2033
80% confidenceHospital Pharmacy held the largest share of 45.87% in 2025
80% confidenceAdult vaccines held the largest share of 39.61% in 2025
80% confidenceResearch & Academic Institutes are forecasted to register the fastest CAGR of 7.21% during 2026–2033
80% confidenceThe Human Vaccines Market size was valued at USD 44.26 billion in 2025 and is expected to reach USD 62.45 billion by 2033, growing at a CAGR of 4.43% during the forecast period of 2026-2033
80% confidenceHospitals accounted for the largest share of 53.12% in 2025
80% confidenceOnline Pharmacy is expected to grow at the fastest CAGR of 6.78% during 2026–2033
80% confidenceThe market is challenged by high development costs, complex manufacturing processes, and strict regulatory requirements
80% confidenceInactivated vaccines held the largest market share of 28.74% in 2025
80% confidenceIntradermal delivery is projected to expand at the fastest CAGR of 6.45% during the forecast period
80% confidenceIntramuscular vaccines accounted for the highest market share of 46.32% in 2025
80% confidencemRNA vaccines are expected to grow at the fastest CAGR of 7.12% during 2026–2033
80% confidenceGeriatric vaccines are expected to grow at the fastest CAGR of 6.98% during 2026–2033
80% confidenceHPV vaccines are anticipated to record the fastest CAGR of 7.34% through 2026–2033
80% confidenceGovernment vaccination programs are an essential factor in the development of the market
80% confidenceCOVID-19 vaccines dominated with a 31.25% share in 2025
80% confidenceNorth America dominated the Human Vaccines Market, accounting for a 34.56% market share in 2025
80% confidence